Literature DB >> 2567696

Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37.

J C Skare1, H L Grierson, J L Sullivan, R L Nussbaum, D T Purtilo, B S Sylla, G M Lenoir, D S Reilly, B N White, A Milunsky.   

Abstract

Analysis of seven kindreds indicates that the XLP locus exhibits 1% recombination with DXS42 (lod = 17.5) and no recombination with DXS37 (lod = 13.3).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567696     DOI: 10.1007/BF00273997

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Report of the Committee on Methods of Linkage Analysis and Reporting.

Authors:  P M Conneally; J H Edwards; K K Kidd; J M Lalouel; N E Morton; J Ott; R White
Journal:  Cytogenet Cell Genet       Date:  1985

2.  A fatal x-linked recessive reticuloendothelial syndrome with hyperglobulinemia. X-linked recessive reticuloendotheliosis.

Authors:  J M Falletta; D J Fernbach; D B Singer; M A South; B H Landing; C W Heath; N A Shore; F F Barrett
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

3.  Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

4.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

5.  Genetic mapping of DNA segments relative to the locus for the fragile-X syndrome at Xq27.3.

Authors:  L M Mulligan; M A Phillips; C J Forster-Gibson; J Beckett; M W Partington; N E Simpson; J J Holden; B N White
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

6.  Malignant lymphoma of the small intestine in multiple family members: association with an immunologic deficiency.

Authors:  H S Maurer; S P Gotoff; L Allen; J Bolan
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

7.  Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq.

Authors:  J C Skare; J L Sullivan; A Milunsky
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Mapping the X-linked lymphoproliferative syndrome.

Authors:  J C Skare; A Milunsky; K S Byron; J L Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment.

Authors:  D S Reilly; R A Lewis; D H Ledbetter; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1988-05       Impact factor: 11.025

View more
  13 in total

Review 1.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

Review 2.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26).

Authors:  J A Nicklas; T C Hunter; J P O'Neill; R J Albertini
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

4.  Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease.

Authors:  V Schuster; S Seidenspinner; T Grimm; W Kress; S Zielen; M Bock; H W Kreth
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

5.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  The technological transformation of patient-driven human immunology research.

Authors:  Helen C Su
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 7.  The molecular basis of X-linked immunodeficiency disease.

Authors:  C Kinnon; R Levinsky
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 8.  Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

Review 9.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

10.  Epstein-Barr virus infection rapidly progressing to monoclonal lymphoproliferative disease in a child with selective immunodeficiency.

Authors:  V Schuster; H W Kreth; H K Müller-Hermelink; H I Huppertz; A C Feller; D Neumann-Haefelin; H Wiegand; N Müller-Lantzsch
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.